# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027698
Filing Date
2021-11-09
Accepted
2021-11-09 17:21:28
Documents
77
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1315676
2 |  | ex-31.htm | EX-31 | 30100
3 |  | ex-32.htm | EX-32 | 7836
| Complete submission text file | 0001493152-21-027698.txt |  | 7917917

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | ocx-20210930.xsd | EX-101.SCH | 73222
5 | XBRL CALCULATION FILE | ocx-20210930_cal.xml | EX-101.CAL | 70836
6 | XBRL DEFINITION FILE | ocx-20210930_def.xml | EX-101.DEF | 313043
7 | XBRL LABEL FILE | ocx-20210930_lab.xml | EX-101.LAB | 549210
8 | XBRL PRESENTATION FILE | ocx-20210930_pre.xml | EX-101.PRE | 438739
9 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1315059

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 211393337
SIC: 2835 In Vitro & In Vivo Diagnostic Substances